Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs

Adam D. Devore, Phillip Schulte, Robert J. Mentz, N. Chantelle Hardy, Jacob P. Kelly, Eric J. Velazquez, Juan F. Maya, Adrian Kielhorn, Harshali K. Patel, Shelby D. Reed, Adrian F. Hernandez

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

There are limited data describing outcomes associated with an elevated heart rate in patients with heart failure with reduced ejection fraction (HFrEF) in routine clinical practice. We identified patients with HFrEF at Duke University Hospital undergoing echocardiograms and heart rate assessments without paced rhythms or atrial fibrillation. Outcomes (all-cause mortality or hospitalization and medical costs per day alive) were assessed using electronic medical records, hospital cost accounting data, and national death records. Patients were stratified by heart rate (<70 and ≥70 beats/min) and compared using generalized linear models specified with gamma error distributions and log links for costs and proportional hazard models for mortality/hospitalization. Of 722 eligible patients, 582 patients (81%) were treated with β blockers. The median heart rate was 81 beats/min (25th and 75th percentiles 69 to 96) and 527 patients (73%) had a heart rate ≥70 beats/min. After multivariate adjustment, a heart rate ≥70 beats/min was associated with increased 1-year all-cause mortality or hospitalization, hazard ratio 1.37 (95% CI 1.07 to 1.75) and increased medical costs per day alive, cost ratio 2.03 (95% CI 1.53 to 2.69). In conclusion, at a large tertiary care center, despite broad use of β blockers, a heart rate ≥70 beats/min was observed in 73% of patients with HFrEF and associated with worse 1-year outcomes and increased direct medical costs per day alive.

Original languageEnglish (US)
Pages (from-to)946-951
Number of pages6
JournalAmerican Journal of Cardiology
Volume117
Issue number6
DOIs
StatePublished - Mar 15 2016

Fingerprint

Heart Failure
Heart Rate
Costs and Cost Analysis
Hospitalization
Mortality
Death Certificates
Hospital Costs
Electronic Health Records
Proportional Hazards Models
Tertiary Care Centers
Atrial Fibrillation
Linear Models

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs. / Devore, Adam D.; Schulte, Phillip; Mentz, Robert J.; Hardy, N. Chantelle; Kelly, Jacob P.; Velazquez, Eric J.; Maya, Juan F.; Kielhorn, Adrian; Patel, Harshali K.; Reed, Shelby D.; Hernandez, Adrian F.

In: American Journal of Cardiology, Vol. 117, No. 6, 15.03.2016, p. 946-951.

Research output: Contribution to journalArticle

Devore, AD, Schulte, P, Mentz, RJ, Hardy, NC, Kelly, JP, Velazquez, EJ, Maya, JF, Kielhorn, A, Patel, HK, Reed, SD & Hernandez, AF 2016, 'Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs', American Journal of Cardiology, vol. 117, no. 6, pp. 946-951. https://doi.org/10.1016/j.amjcard.2015.12.031
Devore, Adam D. ; Schulte, Phillip ; Mentz, Robert J. ; Hardy, N. Chantelle ; Kelly, Jacob P. ; Velazquez, Eric J. ; Maya, Juan F. ; Kielhorn, Adrian ; Patel, Harshali K. ; Reed, Shelby D. ; Hernandez, Adrian F. / Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs. In: American Journal of Cardiology. 2016 ; Vol. 117, No. 6. pp. 946-951.
@article{797523e1981b45dbb17e9928a755ede7,
title = "Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs",
abstract = "There are limited data describing outcomes associated with an elevated heart rate in patients with heart failure with reduced ejection fraction (HFrEF) in routine clinical practice. We identified patients with HFrEF at Duke University Hospital undergoing echocardiograms and heart rate assessments without paced rhythms or atrial fibrillation. Outcomes (all-cause mortality or hospitalization and medical costs per day alive) were assessed using electronic medical records, hospital cost accounting data, and national death records. Patients were stratified by heart rate (<70 and ≥70 beats/min) and compared using generalized linear models specified with gamma error distributions and log links for costs and proportional hazard models for mortality/hospitalization. Of 722 eligible patients, 582 patients (81{\%}) were treated with β blockers. The median heart rate was 81 beats/min (25th and 75th percentiles 69 to 96) and 527 patients (73{\%}) had a heart rate ≥70 beats/min. After multivariate adjustment, a heart rate ≥70 beats/min was associated with increased 1-year all-cause mortality or hospitalization, hazard ratio 1.37 (95{\%} CI 1.07 to 1.75) and increased medical costs per day alive, cost ratio 2.03 (95{\%} CI 1.53 to 2.69). In conclusion, at a large tertiary care center, despite broad use of β blockers, a heart rate ≥70 beats/min was observed in 73{\%} of patients with HFrEF and associated with worse 1-year outcomes and increased direct medical costs per day alive.",
author = "Devore, {Adam D.} and Phillip Schulte and Mentz, {Robert J.} and Hardy, {N. Chantelle} and Kelly, {Jacob P.} and Velazquez, {Eric J.} and Maya, {Juan F.} and Adrian Kielhorn and Patel, {Harshali K.} and Reed, {Shelby D.} and Hernandez, {Adrian F.}",
year = "2016",
month = "3",
day = "15",
doi = "10.1016/j.amjcard.2015.12.031",
language = "English (US)",
volume = "117",
pages = "946--951",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs

AU - Devore, Adam D.

AU - Schulte, Phillip

AU - Mentz, Robert J.

AU - Hardy, N. Chantelle

AU - Kelly, Jacob P.

AU - Velazquez, Eric J.

AU - Maya, Juan F.

AU - Kielhorn, Adrian

AU - Patel, Harshali K.

AU - Reed, Shelby D.

AU - Hernandez, Adrian F.

PY - 2016/3/15

Y1 - 2016/3/15

N2 - There are limited data describing outcomes associated with an elevated heart rate in patients with heart failure with reduced ejection fraction (HFrEF) in routine clinical practice. We identified patients with HFrEF at Duke University Hospital undergoing echocardiograms and heart rate assessments without paced rhythms or atrial fibrillation. Outcomes (all-cause mortality or hospitalization and medical costs per day alive) were assessed using electronic medical records, hospital cost accounting data, and national death records. Patients were stratified by heart rate (<70 and ≥70 beats/min) and compared using generalized linear models specified with gamma error distributions and log links for costs and proportional hazard models for mortality/hospitalization. Of 722 eligible patients, 582 patients (81%) were treated with β blockers. The median heart rate was 81 beats/min (25th and 75th percentiles 69 to 96) and 527 patients (73%) had a heart rate ≥70 beats/min. After multivariate adjustment, a heart rate ≥70 beats/min was associated with increased 1-year all-cause mortality or hospitalization, hazard ratio 1.37 (95% CI 1.07 to 1.75) and increased medical costs per day alive, cost ratio 2.03 (95% CI 1.53 to 2.69). In conclusion, at a large tertiary care center, despite broad use of β blockers, a heart rate ≥70 beats/min was observed in 73% of patients with HFrEF and associated with worse 1-year outcomes and increased direct medical costs per day alive.

AB - There are limited data describing outcomes associated with an elevated heart rate in patients with heart failure with reduced ejection fraction (HFrEF) in routine clinical practice. We identified patients with HFrEF at Duke University Hospital undergoing echocardiograms and heart rate assessments without paced rhythms or atrial fibrillation. Outcomes (all-cause mortality or hospitalization and medical costs per day alive) were assessed using electronic medical records, hospital cost accounting data, and national death records. Patients were stratified by heart rate (<70 and ≥70 beats/min) and compared using generalized linear models specified with gamma error distributions and log links for costs and proportional hazard models for mortality/hospitalization. Of 722 eligible patients, 582 patients (81%) were treated with β blockers. The median heart rate was 81 beats/min (25th and 75th percentiles 69 to 96) and 527 patients (73%) had a heart rate ≥70 beats/min. After multivariate adjustment, a heart rate ≥70 beats/min was associated with increased 1-year all-cause mortality or hospitalization, hazard ratio 1.37 (95% CI 1.07 to 1.75) and increased medical costs per day alive, cost ratio 2.03 (95% CI 1.53 to 2.69). In conclusion, at a large tertiary care center, despite broad use of β blockers, a heart rate ≥70 beats/min was observed in 73% of patients with HFrEF and associated with worse 1-year outcomes and increased direct medical costs per day alive.

UR - http://www.scopus.com/inward/record.url?scp=84959451065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959451065&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2015.12.031

DO - 10.1016/j.amjcard.2015.12.031

M3 - Article

VL - 117

SP - 946

EP - 951

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 6

ER -